Irazú Oncology Secures $2.6M Seed Investment to Advance Innovative Cancer Vaccine Platform
Irazú Oncology Secures $2.6M Seed Investment to Advance Innovative Cancer Vaccine Platform
![](https://biobuzz.io/wp-content/uploads/2022/10/20221014_4MLK_0311-300x300.jpg)
Irazú Oncology Secures $2.6M Seed Investment to Advance Innovative Cancer Vaccine Platform
The technology was developed by the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine.